Clinical and Immune Impact of Mycobacterium bovis BCG Vaccination Scarring
The World Health Organization recommends Mycobacterium bovis BCG vaccination in areas of high tuberculosis prevalence. BCG's clinical and immune effects, not necessarily Mycobacterium tuberculosis specific, are unclear. BCG vaccine scarring often is used as a surrogate marker of vaccination or of ef...
Gespeichert in:
| Veröffentlicht in: | Infect Immun |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Microbiology (ASM)
2002
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC130324/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12379697/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.70.11.6188-6195.2002 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
